Practice Management

Latest News


CME Content


Providence, R.I.-Access to dermatologists by many patients who most need the care-the indigent-is so critically limited that a solution to the problem must be found, concludes a study presented at the recent meeting of the Society for Investigative Dermatology.

Ms. Codit

Most physicians and staff feel relatively comfortable with the global surgical package - what it includes and what it doesn't. I have written numerous articles over the past several years reiterating the details of the concept so that everyone is clear about the rules that govern the global billing package.

Dermatologists and other physicians should be aware of several key recent developments at the Centers for Medicare & Medicaid Services (CMS) that could affect their practices.

Providence, R.I. - Mohs surgery appears to be a more cost-effective strategy for the treatment of facial nonmelanoma skin cancers (NMSCs) compared with traditional surgical excision, although the advantage of Mohs surgery is sensitive to the type of repair performed, according to the results of a study presented by Tracy L. Bialy, M.D., M.P.H., at the annual meeting of the Society for Investigative Dermatology

BOTOX FOR THE BACK

Botox injections may help ease stubborn pain in the neck and upper back when other treatments fail, preliminary research shows. A study of 25 patients whose chronic pain had resisted other therapies found that a single round of Botox injections coupled with physical therapy brought pain relief within a month.

Treatment of hyperhidrosis with botulinum toxin injections or iontophoresis might be covered by insurance, but receiving reimbursement depends on obtaining pre-certification and using the correct billing codes, said Dr. Ramsey F. Markus, M.D.

Prescription drug makers will be required within two years to put bar codes on packaging in an effort to reduce potentially dangerous dispensing errors in hospitals, U.S. health officials said. The bar codes are meant to enable nurses and other healthcare workers to electronically verify that they are giving the right drug at the right dose at the right time. The Bush administration published a final regulation on the bar-coding requirement in February. Under the requirement, each bar code must contain a drug's unique identification number. Companies also may include information on the product's lot number and expiration date. A nurse using the system would scan a patient's identification bracelet and then the drug label, and then a computer would compare the information. An error message would appear if the drug, dose, or time of dose were incorrect.

Ms.Codit

We get many questions about issues that do not warrant an entire column in response. Many of these are asked over and over again. I have collected these and will dedicate the next few months to answering them. I refer to these as "Dermatology Potpourri". Enjoy!

Washington - Researchers have discovered an algorithm that could provide a consistent tool for analyzing cases of mottled hyperpigmentation (MHP) based on photographic images.

Switching to electronic medical records is the smart thing to do. An EMR puts information-legible information, databases of it-right at your fingertips.

Anew option is available to all physicians, whether they seek healthcare insurance coverage for themselves and their families or affordable options for the employees of their practice.

Dallas - Pre-clinical research suggests a new compound can boost the efficacy of diagnostic and laser therapeutic applications. The chemical mixture appears to increase the transparency of normal human skin, thereby allowing a better, deeper and much greater penetration of light for diagnostic and therapeutic purposes.

Dermatologists and other physicians are being caught in the middle of a growing political battle over health care policy, along with 41 million Medicare beneficiaries, as Republicans and Democrats position themselves for political advantage in this critical election year.

As physicians, we're all faced with making decisions about the purchase of new electronic technology that promises to streamline the efficiency of the practice and significantly reduce our overhead expenses. Vendors ply their products and promise us the sun and the moon, yet few office managers and even fewer physicians know how to evaluate these products.

Amgen has gotten Medicare to pay for limited amounts of Enbrel, the $1,000-a-month rheumatoid-arthritis drug. The coverage, tucked in the new Medicare law that covers drugs for seniors, includes some expensive biotech drugs that patients can inject themselves, such as Enbrel and a rival, Abbott Laboratories' Humira.